NINDS invites applications for the NINDS Cooperative Program in Translational Research for resistant epilepsy and epileptogenesis.
Epilepsy is one of the most common neurological disorders affecting both American and international populations and represents a significant source of public health burden. NINDS recognizes the need to encourage innovative research approaches to move toward real cures for epilepsy, defined as “no seizures, no side effects, and prevention in those at risk.” This announcement supports milestone-driven projects focused on the identification, optimization, and preclinical testing of candidate therapeutics for resistant epilepsy and prevention of epileptogenesis.
Potential applicants should contact Dr. Randall Stewart, program director, Channels, Synapses, and Circuits Cluster, NINDS, at 301-496-1917 or email@example.com. For more information visit http://grants.nih.gov/grants/guide/pa-files/PAR-11-154.html.